Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 25% ± 9% | |
| dendritic cell | 3 studies | 23% ± 2% |
Insufficient scRNA-seq data for expression of USP5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 4900.70 | 1445 / 1445 | 100% | 93.64 | 183 / 183 |
| ovary | 100% | 3154.96 | 180 / 180 | 100% | 102.69 | 430 / 430 |
| brain | 100% | 5427.95 | 2637 / 2642 | 100% | 149.33 | 705 / 705 |
| thymus | 100% | 4049.72 | 653 / 653 | 100% | 96.51 | 603 / 605 |
| prostate | 100% | 4201.05 | 245 / 245 | 100% | 96.23 | 500 / 502 |
| skin | 100% | 6087.66 | 1809 / 1809 | 100% | 122.45 | 470 / 472 |
| adrenal gland | 100% | 6709.47 | 258 / 258 | 100% | 147.22 | 229 / 230 |
| breast | 100% | 3445.91 | 459 / 459 | 100% | 114.74 | 1113 / 1118 |
| uterus | 100% | 4412.06 | 170 / 170 | 99% | 108.90 | 456 / 459 |
| intestine | 100% | 4328.66 | 966 / 966 | 99% | 94.83 | 523 / 527 |
| liver | 99% | 2493.20 | 224 / 226 | 100% | 64.41 | 406 / 406 |
| kidney | 100% | 3383.65 | 89 / 89 | 99% | 79.76 | 893 / 901 |
| stomach | 100% | 3301.70 | 358 / 359 | 99% | 83.39 | 283 / 286 |
| lung | 99% | 3203.35 | 574 / 578 | 99% | 106.36 | 1147 / 1155 |
| bladder | 100% | 5202.62 | 21 / 21 | 99% | 107.49 | 497 / 504 |
| pancreas | 96% | 1685.93 | 315 / 328 | 99% | 80.81 | 177 / 178 |
| blood vessel | 100% | 5153.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 91.75 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 107.69 | 29 / 29 |
| muscle | 100% | 6053.29 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3727.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 119.29 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 56.68 | 1 / 1 |
| adipose | 100% | 3483.40 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 95% | 3050.32 | 820 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 74% | 2172.74 | 689 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO_0071108 | Biological process | protein K48-linked deubiquitination |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
| GO_0006508 | Biological process | proteolysis |
| GO_0016579 | Biological process | protein deubiquitination |
| GO_0005764 | Cellular component | lysosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0101005 | Molecular function | deubiquitinase activity |
| GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0043130 | Molecular function | ubiquitin binding |
| Gene name | USP5 |
| Protein name | Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5) Ubiquitin specific peptidase 5 |
| Synonyms | ISOT |
| Description | FUNCTION: Cleaves linear and branched multiubiquitin polymers with a marked preference for branched polymers. Involved in unanchored 'Lys-48'-linked polyubiquitin disassembly. Binds linear and 'Lys-63'-linked polyubiquitin with a lower affinity. Knock-down of USP5 causes the accumulation of p53/TP53 and an increase in p53/TP53 transcriptional activity because the unanchored polyubiquitin that accumulates is able to compete with ubiquitinated p53/TP53 but not with MDM2 for proteasomal recognition. . |
| Accessions | F5H571 ENST00000542087.1 ENST00000389231.9 [P45974-2] P45974 ENST00000229268.13 [P45974-1] |